Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma

Cancer

Volumn 88, Issue 3, 2000, Pages 608-614

  Schrenk, Peter ^a,b   Rieger, Roman ^a   Shamiyeh, Andreas ^a   Wayand, Wolfgang ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Axillary lymph node dissection; Breast carcinoma; Complications; Postoperative morbidity; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHEDEMA; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ARM; AXILLA; BIOPSY; BREAST NEOPLASMS; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPESTHESIA; LYMPH NODE EXCISION; LYMPHEDEMA; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MOVEMENT; MUSCLE CONTRACTION; NEOPLASM STAGING; PAIN, POSTOPERATIVE; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT;

EID: 0034141681     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K     Document Type: Article

References (38)

1. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
2. Fisher B, Bauer M, Wickerham L, Redmond CK, Fisher ER. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983; 52:1551-7.
3. Dees EC, Shulman LN, Souba WW, Smith BL. Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? Ann Surg 1997;226:279-87.
4. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham L, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674-81.
5. Benson EA, Thorogood J. The effect of surgical technique on local recurrence rates following mastectomy. Eur J Surg Oncol 1986;12:267-71.
6. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer. Cancer 1995;76:1491-512.
7. Budd DC, Cochran RC, Sturtz DL, Fouty WJ Jr. Surgical morbidity after mastectomy operations. Am J Surg 1978;135: 218-20.
8. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136-8.
9. Maunsell E, Brisson J, Deschenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36:315-20.
10. Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, et al. Complications of axillary lymph node dissection for carcinoma of the breast. Cancer 1998;83: 1362-8.
11. Cady B. Is axillary lymph node dissection necessary in routine management of breast cancer? No. Breast J 1997;5:246-60.
12. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
13. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
14. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271-8.
15. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes. Lancet 1997;349:1864-7.
16. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227: 645-53.
17. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998;339:941-6.
18. O'Hea BJ, Hill ADK, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-7.
19. Reintgen D, Albertini J, Milliotes G, Marshburn J, Cruse CW, Rapaport D, et al. Investment in new technology research can save future health care dollars. J Florida Med Assoc 1997;84:175-81.
20. Flett MM, Going JJ, Stanton PD, Cooke TG. Sentinel node localization in patients with breast cancer. Br J Surg 1998; 85:991-3.
21. Schrenk P, Hatzl M, Rieger R, Shamiyeh A, Wayand W, Maschek W. Klinische Anwendung der Biopsie des leitenden Lymphknotens beim Mammacarcinom. Chirurg 1998;69: 1072-6.
22. Larson D, Weinstein M, Goldberg I, Silver B, Recht A, Cady B, et al. Edema of the arm as a function of the extent of axillary surgery in patients with Stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:1575-82.
23. Pezner RD, Patterson MP, Hill RL, Lipsett JA, Desai KR, Vora N, et al. Arm lymphedema in patients treated conservatively for breast cancer: relationship to patient age and axillary node dissection technique. Int J Radiation Oncology Biol Phys 1986;12:2079-83.
24. Delouche G, Bachelot F, Premont M, Kurtz JM. Conservation treatment of early breast cancer: long term results and complications. Int J Radiat Oncol Biol Phys 1987;13:29-34.
25. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986;73:580-4.
26. Thompson AM, Air M, Jack WJL, Kerr GR, Rodger A, Chetty U. Arm morbidity after breast conservation and axillary therapy. Breast 1995;4:273-6.
27. Swedborg I, Wallgren A. The effect of pre- and postmastectomy radiotherapy on the degree of edema, shoulder-joint mobility, and gripping force. Cancer 1981;47:877-81.
28. Christensen SB, Lundgren E. Sequelae of axillary dissection vs. axillary sampling with or without irradiation for breast cancer: a randomized trial. Acta Chir Scand 1989;155:515-20.
29. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer 1994;73: 664-7.
30. Wazer DE, Erban JK, Robert NJ, Smith TJ, Marchant DJ, Schmid C, et al. Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection. Cancer 1994;74:878-83.
31. Fein DA, Fowble BL, Hanlon AL, Hooks MA, Hoffman JP, Sigurdson ER, et al. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J. Surg Oncol 1997;65:34-9.
32. Chadha M, Axelrod D. Is axillary dissection always indicated in invasive breast cancer? Oncology 1997;11:1463-8.
33. White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI. Therapeutic options and results for the treatment of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg 1996;183:575-82.
34. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma. Cancer 1997;80: 1188-97.
35. Davies GC, Millis RR, Hayward IL. Assessment of axillary lymph node status. Ann Surg 1980;192:148-51.
36. Kissin MW, Thompson EM, Price AB, Slavin G, Kark AE. The inadequacy of axillary sampling in breast cancer. Lancet 1982;1(8283):1210-2.
37. Pigott J, Nichols R, Maddox WA, Balch CM. Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures. Surg Gynecol Obstet 1984;158:255-9.
38. Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Discontinuous or "skip metastases" in breast carcinoma: analysis of 1228 axillary dissections. Ann Surg 1983;197:276-83.